Alpha Tau Medical Ltd. current report, Q2 FY2022

Alpha Tau Medical Ltd. — Form 6-K Summary

Reporting period: June 2022; filed June 7, 2022. The filing reports a corporate governance change and does not provide financial statements or operating results.

Business Context and Corporate Action

Alpha Tau Medical Ltd. announced that Gary Leibler resigned, effective immediately, from the company’s board of directors and its audit committee. The company stated that the resignation was for reasons unrelated to the company.

Financial Metrics and Liquidity

The filing does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, or other financial metrics.

Material Changes

  • Immediate resignation of Gary Leibler from the board of directors.
  • Immediate resignation of Gary Leibler from the audit committee.
  • No replacement or committee reconstitution was disclosed in the filing.

Guidance, Outlook, Risks, and Unusual Items

No guidance, outlook, management commentary on operations, risk updates, contingencies, or unusual financial items were disclosed. The filing states that the resignation was unrelated to the company.

Investor Verification Points

  • Verify any subsequent appointment to the board or audit committee.
  • Review later filings for changes to audit committee composition or governance practices.
  • Refer to the company’s periodic financial filings for operating results, liquidity, capital resources, and risk disclosures.